Olanzapine for Cocaine Craving and Relapse Prevention in 2 Patients
J Clin Psychiatry 2002;63(7):595-596 [letter]
© Copyright 2015 Physicians Postgraduate Press, Inc.
Purchase This PDF for $40.00
If you are not a paid subscriber, you may purchase the PDF.
(You'll need the free Adobe Acrobat Reader.)
Receive immediate full-text access to JCP. You can subscribe to JCP online-only ($86) or print + online ($156 individual).
With your subscription, receive a free PDF collection of the NCDEU Festschrift articles. Hurry! This offer ends December 31, 2011.
If you are a paid subscriber to JCP and do not yet have a username and password, activate your subscription now.
As a paid subscriber who has activated your subscription, you have access to the HTML and PDF versions of this item.
Click here to login.
Did you forget your password?
Still can't log in? Contact the Circulation Department at 1-800-489-1001 x4 or send email
Letter to the Editor
Sir: A major focus of research in treatment for cocaine and stimulant dependence has been pharmacologic interventions to decrease craving and prevent relapse. Various medications have shown promise in uncontrolled clinical trials, but most fail to show consistent advantage over placebo in double-blind, placebo-controlled trials. Despite this, many practitioners continue to try various medications in an effort to find some means of decreasing cocaine use in dependent patients.